Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.
Press releases published on May 6, 2025
Allogene Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update
GlobeNewswire
·
May 6, 2025
Conference Call and Webcast Scheduled for May 13, 2025 at 2:00 p.m. PT/5:00 p.m. ET SOUTH SAN FRANCISCO, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development …
Cellebrite stellt die Version für das Frühjahr 2025 vor, um weltweite Untersuchungen zu beschleunigen
GlobeNewswire
·
May 6, 2025
TYSONS CORNER, Virginia, und PETAH TIKVA, Israel, May 06, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), ein weltweit führender Anbieter von erstklassigen digitalen Untersuchungslösungen für den öffentlichen und privaten Sektor, hat heute seine …
Cellebrite dévoile sa version Printemps 2025 pour accélérer les enquêtes à l’échelle mondiale
GlobeNewswire
·
May 6, 2025
TYSONS CORNER, Virginie et PETAH TIKVA, Israël, 06 mai 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ : CLBT), leader mondial des solutions d’enquête numérique à destination des secteurs public et privé, annonce ce jour la sortie de sa version Printemps 2025, …
Orangekloud to Attend Directions ASIA 2025 Conference, May 7-9, in Bangkok
GlobeNewswire
·
May 6, 2025
SINGAPORE, May 06, 2025 (GLOBE NEWSWIRE) -- Orangekloud Technology Inc. (Nasdaq: ORKT) (“Orangekloud” or “the Company”), a pioneer in AI-driven no-code application development, today announced that the Company will be attending the Directions ASIA 2025 …
Windtree Announces Istaroxime Exclusivity and Intellectual Property Potential Strategy for US
GlobeNewswire
·
May 6, 2025
WARRINGTON, Pa., May 06, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue generating company and advancing early and late-stage innovative therapies …
Atsign Supercharges File Sharing with Invisible SMB/CIFS Connections
GlobeNewswire
·
May 6, 2025
SAN JOSE, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Atsign, the leader in invisible zero trust connectivity solutions, today announced that its NoPorts technology now supports invisible SMB/CIFS connections. This breakthrough enables users to access file …
Plotly Showcases AI-powered Platform for Interactive Data Application Development at Leading Industry Events in May and June 2025
GlobeNewswire
·
May 6, 2025
MONTREAL, May 06, 2025 (GLOBE NEWSWIRE) -- Plotly, the premier Data App platform for Python, today announced it will participate in multiple leading industry events in May and June, 2025, where Plotly experts and users will share their unique insights and …
FOXO TECHNOLOGIES INC.’S BEHAVIORAL HEALTH SUBSIDIARY REACHES KEY OPERATIONAL MILESTONES
GlobeNewswire
·
May 6, 2025
WEST PALM BEACH, FLORIDA, May 06, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”) today announced that its behavioral health subsidiary, Myrtle Recovery Centers, Inc., has reached key patient care milestones. …
IMUNON Announces Data from Phase 1/2 Trial Evaluating Intraperitoneal IMNN-001 in Combination with Neoadjuvant Chemotherapy in Newly Diagnosed Patients with Advanced Epithelial Ovarian Cancer to be Published in Gynecologic Oncology
GlobeNewswire
·
May 6, 2025
Data from OVATION 2 trial will also be reviewed in an oral presentation at ASCO Annual Meeting on June 3, 2025 LAWRENCEVILLE, N.J., May 06, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development with its …
Candel Therapeutics to Present at Upcoming Investor Conferences
GlobeNewswire
·
May 6, 2025
NEEDHAM, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, …
Ardelyx Presents Data Supporting IBSRELA® (tenapanor) at Digestive Disease Week 2025 Conference
GlobeNewswire
·
May 6, 2025
WALTHAM, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …
Digital Cameras Big Savings Alert: Save on Nikon, Canon, and Sony Flagship Cameras for a Limited Time, Top Camera Deals Now Live at B&H Photo
GlobeNewswire
·
May 6, 2025
Photography enthusiasts and professionals alike can now take advantage of some of the industry’s most coveted cameras. B…
Great Lakes Reports First Quarter 2025 Results
GlobeNewswire
·
May 6, 2025
First quarter net income of $33.4 million First quarter Adjusted EBITDA of $60.1 million Dredging backlog of $1 billion at March 31, 2025 HOUSTON, May 06, 2025 (GLOBE NEWSWIRE) -- Great Lakes Dredge …
Boehringer Ingelheim starts Phase II study of its potential first-in-class oral compound as a treatment for Geographic Atropy
GlobeNewswire
·
May 6, 2025
Ingelheim, Germany, May 6, 2025 – Boehringer Ingelheim today announces the start of the JADE Phase II clinical study (NCT06769048), investigating the efficacy and safety of BI 1584862 as a potential first-in-class treatment for geographic atrophy (GA).[1 …
Nuvectis Pharma, Inc. Reports First Quarter 2025 Financial Results and Business Highlights
GlobeNewswire
·
May 6, 2025
NXP900 clinical data presentation from the Phase 1a dose escalation study at the 2025 American Association for Cancer Research (AACR) conference demonstrated robust pharmacodynamic response and acceptable safety at clinically relevant doses; preclinical …
AMRT Satellite Technology Uncovers Significant Mineral Assets at Historic Oregon Mine
EIN Presswire
·
May 6, 2025
Abandoned Mine Expected to Roar Back to Life with Massive Results thanks to AMRT Satellite Scan Technology MESA, AZ, UNITED STATES, May 6, 2025 /EINPresswire.com/ -- CC Explorations, a leading satellite-based mineral exploration company, today announced …
R3 Stem Cell Opens First Rate New Clinic in Puerto Vallarta Mexico
EIN Presswire
·
May 6, 2025
R3 Stem Cell is now treating patients at a new clinic in Puerto Vallarta Mexico. The clinic offers a full slate of first rate stem cell and exosome therapies. SCOTTSDALE, AZ, UNITED STATES, May 5, 2025 /EINPresswire.com/ -- R3 Stem Cell announced today …
ReportAId raises €2.2M using AI to unlock healthcare data
GlobeNewswire
·
May 6, 2025
Milan, May 06, 2025 (GLOBE NEWSWIRE) -- Ask any doctor what's keeping them from delivering better care, and paperwork will top the list. Despite billions invested in healthcare technology, 80% of clinical data remains trapped in unstructured reports, and …
Changes in Nokia Corporation's own shares
GlobeNewswire
·
May 6, 2025
Nokia Corporation Stock Exchange Release 6 May 2025 at 15:00 EEST Changes in Nokia Corporation's own shares Espoo, Finland – A total of 139 888 Nokia shares (NOKIA) held by the company were transferred today without consideration to participants of Nokia's …
Muutokset Nokia Oyj:n omien osakkeiden omistuksessa
GlobeNewswire
·
May 6, 2025
Nokia Oyj Pörssitiedote 6.5.2025 klo 15.00 Muutokset Nokia Oyj:n omien osakkeiden omistuksessa Espoo – Nokia on tänään luovuttanut 139 888 yhtiön hallussa ollutta Nokian osaketta (NOKIA) vastikkeetta suorituksena Nokian osakepohjaisiin kannustinohjelmiin …